Ten alleles with length and nucleotide sequence variations were identified in the regulatory region of human tissue kallikrein gene. This present study aimed to study the polymorphisms of the regulatory region of human tissue kallikrein gene of the Chinese and investigate the relationship of the polymorphisms with essential hypertension. A case-control study was conducted in 200 hypertensive and 200 normotensive subjects of unrelated Chinese Han origin. All subjects were aged from 30 to 70 years and had no history of diabetes mellitus, kidney failure, or thyroid gland disease. The alleles were detected by polymerase chain reaction (PCR) and genotyping was performed with allele-specific oligonucleotide analysis (ASO). Data from the essential hypertensive and control subjects were statistically analysed by the Student's t-test and v 2 -test. The ageand gender-matching of the groups were accurate. The case group and the control group were in HardyWeinberg equilibrium at this locus (cases, P ¼ 0.313; control subjects, P ¼ 0.457). There were nine alleles among the case and control groups, and the allele frequencies were found to be significantly different between cases and controls (v 2 ¼ 25.701, Po0.001). The genotype frequencies were also significantly different (v 
Introduction
Hypertension is a common, modifiable risk factor for coronary artery and cerebrovascular diseases. These diseases are major causes of morbidity and mortality in both developed and developing countries. Although the cause of essential hypertension consists of genetic, environmental, and demographic factors, and all these factors contribute to it interactively, it is a challenge to isolate the genetical influence related to the disease. Among candidate genes thus investigated to date, tissue kallikrein gene has drawn substantial attention. The human tissue kallikrein is the major kinin-forming enzyme in the kidney. 1 Kallikrein is synthesized in the distal tubules and released in urine and the peritubular interstitium. Kinin peptides are implicated in many physiological and pathological processes, including the regulation of blood pressure and sodium homeostasis, inflammation and the cardioprotective effects of preconditioning. 2 Several studies have documented the role of the kallikrein-kinin system and its interaction with the renin-angiotensin system in the regulation of the medullary and papillary circulation. 3, 4 The KLK1 gene (The kallikrein gene) is located on the long arm of chromosome 19(19q13.2-13.4) . 5 This gene contains five exons, spanning 45.2 kb, and codes for an inactive prokallikrein form, which is activated by intracellular proteolysis of a short amino-terminal peptide. 6 Recently, studies of molecular genetics have revealed single-nucleotide polymorphisms modify the function of single genes, thereby leading to unambiguous phenotypes in hypertension. 7 Presumably, DNA alleles (variants) may alter the function or expression of the gene or its encoded protein. The polymorphisms of tissue kallikrein gene have been shown to be associated with blood pressure regulation in spontaneous hypertensive rats. 8 Transgenic mice overexpressing the human tissue kallikrein gene has been shown to exhibit a hypotensive phenotype. 9 Further, on the basis of studies of large Utah pedigrees, Berry et al 10 have suggested that a major gene effect accounts for one-half of the variance of the trait, with a dominant allele being associated with high urinary kallikrein activity and a reduced risk of hypertension.
Identification of DNA polymorphisms provides an efficient way to study the association of genes and diseases by linkage analysis. Berge and Berg 11 found a Taq I restriction fragment length polymorphism at this locus in a Norwegian population, and found three additional allelic polymorphisms, including one leading to an amino-acid substitution (Arg53His). But no significant linkage was found between blood pressure and the kallikrein gene using this marker. 12 Richards et al 0 -flanking region of the human tissue kallikrein gene for polymorphism in 108 unrelated subjects, consisting of 57 Caucasians, 33 AfricanAmericans, and 18 Asians. They identified one polymorphic region between nucleotides À121 and À133 with respect to the transcription initiation site of the tissue kallikrein gene.
14 Rola et al identified nine single-nucleotide polymorphisms of the human kallikrein gene, of which five polymorphisms were not reported previously. The results suggest the R53H polymorphism was associated with reduced urinary kallikrein activity, but had no relationship with blood pressure. 15 However, those studies were based on limited samples. Particularly most of them were not random samples. Therefore, we undertook a study of Chinese Han people in Sichuan province by using PCR and ASO analysis. A case-control study was conducted in 200 hypertensive and 200 normotensive subjects, with the w 2 -test used to test the significance of difference between the case and control groups.
Materials and methods

Subjects
The study was based on random samples. All participants were of unrelated Chinese Han origin and were living in the Sichuan province. This region was divided into five areas: the east, the west, the south, the north and the centre. From each area, blood samples and information of both groups were collected in hospitals. The number of cases and controls from each city was approximately proportional to the local population. Among those who gave consent for participation and provided blood samples for DNA analysis, 453 individuals were initially selected for a case-control study.
Hypertension (n ¼ 200) was defined according to the following criteria: (1) after 5 min of rest, the seated systolic blood pressure (SBP) was X140 mmHg, the diastolic blood pressure (DBP) was X90 mmHg, or both; (2) age 430 and o70 years; (3) patients receiving long-term antihypertensive treatments; (4) secondary hypertension was excluded by physical examination and biochemical and radiological investigation; (5) no subject had a history of diabetes mellitus, kidney failure, thyroid gland disease, alcoholism or any form of drug abuse.
Control subjects (n ¼ 200) were random sample selected on the basis of the following criteria: (1) the seated SBP was o140 mmHg, the DBP was o90 mmHg, or both; (2) age 430 years and o70 years; (3) no subject had ever received antihypertensive therapy or treatment for heart disease; (4) no subject had a history of diabetes mellitus, kidney failure, thyroid gland disease, alcoholism or any form of drug abuse.
We obtained ethics-committee approval from the local research committee. Each subject gave their written informed consent.
Clinical characteristics of subjects
All participants' height, weight, the SBP, the DBP, total cholesterol (TC, mmol/l), triglyceride (TG, mmol/l), and fasting blood glucose (FBG, mmol/l) were recorded. Family history for hypertension was carefully evaluated by a questionnaire filled with the assistance of a physician. A positive family history was defined as the presence of at least one first-degree relative with high blood pressure that required treatment.
Isolation of DNA
Blood was taken into heparin-containing receptacles and DNA was extracted by means of a standard phenol-chloroform method.
PCR amplification
The primers for PCR were based on cDNA sequence. primers as previously described. PCR was performed in a 50-ml reaction mixture containing 0.1 mg genomic DNA, 1 ml of each primer (10 mM), 4 ml dNTP (2.5 mM), 2 U of Taq polymerase, 4 ml MgCl 2 (25 mM), 5 ml 10 Â buffer. Each amplification was performed as follows: 941C for 5 min to denature followed by 941C for 1 min, 621C for 40 s, and 721C for 1 min for 30 cycles, and 721C for 7 min.
ASO hybridization
Genotyping of all subjects was performed with ASO.
Ten specific digoxin-labelled oligonucleotides synthesized by QIAGEN-Operon Company in Germany are presented in Table 1 . After enzymatic amplification, the PCR product was denatured in 90 ml of 0.4 mol/l. NaOH and 90 ml of 25 mmol/l NaCl and blotted onto nylon membranes (N þ ). Each membrane was preincubated for 2 h at the hybridization temperature, and then it was incubated for 5-6 h with the labelled probe specific to the allele at the hybridization temperature. The membranes were washed twice at hybridization temperature in 2 Â SSC for 5 min, followed by 5 min in 0.1 Â SSC at hybridization temperature. The DIG nucleic acid detection kit was obtained from QIAGEN-Operon Company in Germany. After about 10-12 h of colour development, the positive signal changes to blue-coloured; the negative signals have no colour.
Genotype identity was confirmed by direct sequencing. 300 subjects (150 cases and 150 controls) had been sequenced. Results of the direct sequencing were in agreement with the observation in our study.
Statistical analysis
Data from the essential hypertensive subjects and control subjects were age-and sex-adjusted and were statistically analysed using the Student's t-test. Hardy-Weinberg equilibrium (HWE) of genotype distribution in hypertensive subjects and controls was tested by HWE programme. The w 2 -test was used to compare the observed allele and genotype frequencies between the case and control groups.
Results
Demographic data
The details of cases and control subjects are given in Table 2 . The age-and gender-matching of the groups was accurate. The subjects were aged from 30 to 70 years. TC and TG levels were significantly higher in case than in control subjects. When comparing the two study groups, TC levels (mmol/l) were 4.9970.78 vs 4.7170.73 (Po0.001); likewise, TG levels (mmol/l) were 1.6870.83 vs 1.3370.69 (Po0.001). No significant difference was observed for FBG levels between case and control groups (P ¼ 0.185). Blood pressure in the hypertensive group was significantly higher than in the control group (Po0.001). No significant difference was observed for BMI between case and control groups (P ¼ 0.588). Positive family history in the hypertensive group was significantly higher than that in the control group (P ¼ 0.045).
Genetic analysis
The case and control groups were in HWE (cases, P ¼ 0.313; control subjects, P ¼ 0.457). The distribution of alleles in the case and control populations is shown in Table 3 . The allele frequencies were significantly different between cases and controls (w 2 ¼ 25.701, Po0.001). Nine alleles were found among the case and control groups in the Chinese Han people. Alleles A, B and H had the highest prevalence in these subjects, while alleles C, D and K were also present at high frequencies in these subjects. It was noticed that some alleles (E, I and P) were present at low frequencies. The F allele was not found in these subjects. D and H levels were higher in the cases than that in the control subjects.
The distribution of genotypes in the case and control populations is shown in Table 4 . The genotype frequencies were also significantly different (w 2 ¼ 70.100, Po0.001) between the two groups. There were 37 genotypes among the case and control groups. The AI, DI, EI, EK, EP and KI genotypes were absent in these subjects. The frequencies of AH, BH, CH and HH genotypes were significantly higher in cases than that in controls.
The distribution of genotypes of D and H in the case and control populations is shown in Table 5 . These genotype frequencies were significantly different (w 2 ¼ 22.271, Po0.001) between the cases and The case group and the control group were in Hardy-Weinberg equilibrium (cases, P ¼ 0.313; control subjects, P ¼ 0.457). The allele frequencies were significantly different between cases and controls (w 2 ¼ 25.701, Po0.001). Alleles A, B and H had the highest prevalence in these subjects, while alleles C, D and K were also present with high frequencies in these subjects. It was noticed that some genotypes (E, I and P) are present with low frequencies. The F allele was not found in these subjects. The genotype frequencies were significantly different (w 2 ¼ 70.100, Po0.001) between these two groups. There were 37 genotypes among the case and control groups. The AI, DI, EI, EK, EP and KI genotypes were absent in these subjects. The frequencies of AH, BH, CH and HH genotypes were significantly higher in case than that in control subjects. 
Discussion
Hypertension is a frequent, chronic, age-related disorder, which often entails debilitating cardiovascular and renal complications. Technological advances led to the discovery of 17 human genes that caused Mendelian forms of either hypertension or hypotension. 16 Hypertension mostly arises as a complex quantitative trait that is affected by a varying combination of genetic and environmental factors. 17 Kallikreins are a group of serine proteases that are now divided into two major categories: plasma kallikrein and tissue kallikrein. Tissue kallikrein (KLK1) processes kininogen substrate and releases vasoactive kinin peptide. 18, 19 Epidemiological studies have documented an inverse relationship between urinary kallikrein levels and blood pressure elevation in essential hypertension. 20 Oral administration of purified pig pancreatic kallikrein has been used to temporarily lower both the supine and upright blood pressure of hypertensive patients. 21, 22 Local delivery of the human tissue kallikrein gene causes a sustained blood pressure reduction in SHR. 23 These findings suggest that low renal kallikrein may contribute to hypertension and that high urinary kallikrein may provide a protective effect against the development of high pressure and renal diseases.
Although the role of tissue kallikrein gene in blood pressure regulation has been confirmed in other races, it has not been verified in a Chinese population by linkage analysis. One frequently proposed hypothesis is the existence of ethnic differences among populations studied in hypertension genetics. Song searched the 5 0 -flanking region of the human tissue kallikrein gene for polymorphism in 108 unrelated subjects, consisting of 57 Caucasians, 33 African-Americans, and 18 Asians. The greatest variability was found in the AfricanAmerican population, in which all of the alleles were detected. Six alleles (A, B, E, H, I and K) were observed in Caucasian subjects, and four alleles (A, B, H and K) were found in Asian subjects. Some genotypes (C, D, F and P) occurred only in AfricanAmericans, and type E and I were rare among Caucasians and Asians.
14 It was reported that 51% of the variance of 12-h overnight urinary kallikrein excretion was attributed to a dominant allele and 27% was attributed to the combined effects of polygenes and shared family environment. 10 Our study identified that there were polymorphisms in the regulatory region of the human tissue kallikrein gene in the Chinese Han people. This region was unusually polymorphic, containing a poly-guanine length polymorphism coupled with multiple substitution polymorphisms that constitute at least 10 different haplotypes in the À121 to À131 nucleotides from the transcription initiation site. We found nine alleles and 37 genotypes among the case and control groups. Alleles A, B and H had the highest prevalence in these subjects. Some alleles (E, I and P) were present with low frequencies. The F allele was not found in these subjects. The AI, DI, EI, EK, EP and KI genotypes were absent in these subjects. One possibility may be that the population frequencies of this gene vary from different ethnic groups. Different alleles or genotypes may exert different blood pressure-regulating effects in different ethnic groups. The other possibility may be that the distribution of alleles in a population also depends on the age of the allele. The allele with an old history would (subject to local natural selection and genetic drift) spread globally by the subsequent migration. By contrast, the distribution of a younger allele, which emerged during or after the geographical dispersion of human beings, would be limited. 24 This present study found D and H levels were higher in the cases than in the control subjects. On comparing groups 1, 2 and 4 in And it seemed that the risk increased as the number of such target alleles increased (u ¼ 4.654, Po0.01). These results are in agreement with the observation that allele H exhibited 10-20% promoter activity compared with other alleles, and allele D showed less than 50% promoter activity.
14 Of course, the effects of kallikrein polymorphisms on blood pressure may be more subtle and depend on the environment as well, especially the sodium and potassium levels in the diet. 25 A wide variety of strategies and techniques are currently available to detect mutations. These methods fall into two groups: one for detection of unknown mutations in a region of interest within chromosomes in the population (screening methods) and the other for rapid recognition of known mutations (diagnostic methods). These methods include ribonuclease cleavage, carbodiimide modification, chemical cleavage of mismatch, singlestranded conformation polymorphism (SSCP), heteroduplex analysis, denaturing gradient-gel electrophoresis, constant denaturing gel electrophoresis, and direct sequencing for the first group, as well as allele-specific oligonucleotide, ligation chain reaction, and primer extension for the second group. 26 In this study, we detected the polymorphism by ASO. To test the binding specificity of the allele-specific oligonucleotides to the PCR products, different amounts of PCR products from DNAs with different allelic types were applied to the hybridization system. The outcome showed that binding of the oligonucleotides to the corresponding PCR products was specific and exact. As the intensity of the signals increased with the increasing amounts of PCR products, the intensities of the unspecific binding were unchanged. The hybridization process was convenient to handle, and the results could be visualized directly from the strips. In our system, the oligonucleotides specific for variant nine mutant alleles were divided into three groups and handled synchronously according to its hybridization temperature. We could screen 100 samples for all nine probes within 1 week. Genotyping with ASO is highly reliable. A total of 300 subjects (150 cases and 150 controls) had been sequenced. Results of the direct sequencing were in agreement with the observation in our study.
In conclusion, it is the first study to verify the polymorphisms of tissue kallikrein gene in Chinese Han people. Differences in both allele frequencies and genotype frequencies between the case and control groups may provide some insight into the pathogenesis of essential hypertension in Chinese Han people. Further investigation in a variety of ethnic groups may contribute to the clarity of the association between tissue kallikrein polymorphisms and hypertension.
